Bareminerals Blemish Rescue Skin-clearing Loose Foundation Powder
NDC Package 98132-237-03
Package Information
Bareminerals Blemish Rescue Skin-clearing Loose Foundation (salicylic acid) powders is a medication used on the skin to treat common skin and foot (plantar) warts. This formulation utilizes a powder delivery system. Marketed by Orveon Global Us Llc, this product is identified by NDC 98132-237 and is authorized under FDA application M006.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 98132 - Orveon Global Us Llc
- 98132-237 - Bareminerals Blemish Rescue Skin-clearing Loose Foundation
- 98132-237-03 - 1 JAR in 1 CARTON / .75 g in 1 JAR
- 98132-237 - Bareminerals Blemish Rescue Skin-clearing Loose Foundation
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (98132-237). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 98132-237-03 identifies a specific commercial package of 1 jar in 1 carton / .75 g in 1 jar of Bareminerals Blemish Rescue Skin-clearing Loose Foundation Medium 3c, a human over the counter drug labeled by Orveon Global Us Llc. This powder is formulated for topical use and contains salicylic acid as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Orveon Global Us Llc on December 01, 2019. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used on the skin to treat common skin and foot (plantar) warts. Salicylic acid helps cause the wart to gradually peel off. This medication is also used to help remove corns and calluses. This product should not be used on the face or on moles, birthmarks, warts with hair growing from them, or genital/anal warts. Salicylic acid is a keratolytic. It belongs to the same class of drugs as aspirin (salicylates). It works by increasing the amount of moisture in the skin and dissolving the substance that causes the skin cells to stick together. This makes it easier to shed the skin cells. Warts are caused by a virus. Salicylic acid does not affect the virus.
How is this Orveon Global Us Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 98132023703. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.